JPND
Alzheimer and other Neurodegenerative Diseases
The EU Joint Programme – Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases. JPND aims to increase coordinated investment between participating countries in research aimed at finding causes, developing cures, and identifying appropriate ways to care for those with neurodegenerative diseases.
Neurodegenerative Diseases is one of the 'grand challenges' which faces EU society. Grand challenges are issues such as climate change, food and energy security. Realistically they are beyond the capacity of any individual country to resolve, and would benefit from a co-ordinated approach to research.
Important Documents
- JPND 2012 Strategic Research Agenda
- JPND 2019 Strategic Research and Innovation Agenda
- First-phase Implementation plan 2012-2014
Joint Actions
In 2016-2017, a mapping exercise of research in neurodegenerative diseases has been conducted to obtain an overview of the scale and scope among JPND countries. A research initiative operating under the umbrella of JPND is the Centres of Excellence in Neurodegeneration (COEN) Initiative, which aims to focus expertise within existing investments in recognised biomedical centres of excellence to address some of the immediate barriers to progress and wider collaborative working within these centres.
Calls
2011: Optimisation of biomarkers and harmonisation of their use
2012: Genetic, epigenetic and environmental risk and protective factors
2012: Evaluation of health care policies, strategies and interventions
2013: Cross-disease analysis of pathways related to neurodegenerative diseases
2013: Preventive strategies related to neurodegenerative diseases
2014: Working groups to inform cohort studies
2015: Risk and protective factors; Longitudinal cohort approaches; and Advanced experimental models
2016: Working groups for harmonisation and alignment in brain imaging methods
2017: Pathway analysis across neurodegenerative diseases
2018: Health and Social Care Research and Innovation
2019: Personalised Medicine